Replies to post #32354 on Biotech Values

[Praveen]

I remember one more though I don't follow it.Cytofab, an anti-TNF-alpha polyclonal antibody fragment entering a single phase III study in 2007 for the treatment of severe sepsis.It is from Protherics and is partnered by AZN.

http://www.protherics.com/products/development.aspx

Regards,
Praveen